Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1992;85:1973-1986

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keating, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keating, M.

Circulation, Vol 85, 1973-1986, Copyright © 1992 by American Heart Association


ARTICLES

Linkage analysis and long QT syndrome. Using genetics to study cardiovascular disease

M Keating
Department of Human Genetics, University of Utah Health Sciences Center, Salt Lake City.

BACKGROUND. Recombinant DNA technologies have facilitated the development of a set of polymorphic DNA markers covering the human genome. General linkage analysis in families predisposed to inherited disease is now feasible. Linkage analysis can help identify a disease gene even when relatively little is known about the disorder. METHODS AND RESULTS. Using this approach, we have identified linkage between a gene that causes the long QT syndrome and DNA markers on chromosome 11. CONCLUSIONS. The identification of the chromosomal location of the long QT locus is the first step in defining the specific mutations that cause this disease.


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
T. Nakajima, T. Furukawa, Y. Hirano, T. Tanaka, H. Sakurada, T. Takahashi, R. Nagai, T. Itoh, Y. Katayama, Y. Nakamura, et al.
Voltage-shift of the current activation in HERG S4 mutation (R534C) in LQT2
Cardiovasc Res, November 1, 1999; 44(2): 283 - 293.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
I. Splawski, K. W. Timothy, G. M. Vincent, D. L. Atkinson, and M. T. Keating
Molecular Basis of the Long-QT Syndrome Associated with Deafness
N. Engl. J. Med., May 29, 1997; 336(22): 1562 - 1567.
[Full Text] [PDF]


Home page
CirculationHome page
M. H. Lehmann, S. Hardy, D. Archibald, B. Quart, and D. J. MacNeil
Sex Difference in Risk of Torsade de Pointes With d,l-Sotalol
Circulation, November 15, 1996; 94(10): 2535 - 2541.
[Abstract] [Full Text]


Home page
CirculationHome page
M. T. Keating
Genetic Approaches to Cardiovascular Disease : Supravalvular Aortic Stenosis, Williams Syndrome, and Long-QT syndrome
Circulation, July 1, 1995; 92(1): 142 - 147.
[Abstract] [Full Text]


Home page
CirculationHome page
P. A. Brink, A. Ferreira, J. C. Moolman, H. W. Weymar, P.-L. van der Merwe, and V. A. Corfield
Gene for Progressive Familial Heart Block Type I Maps to Chromosome 19q13
Circulation, March 15, 1995; 91(6): 1633 - 1640.
[Abstract] [Full Text]


Home page
JAMAHome page
R. R. Makkar, B. S. Fromm, R. T. Steinman, M. D. Meissner, and M. H. Lehmann
Female Gender as a Risk Factor for Torsades de Pointes Associated With Cardiovascular Drugs
JAMA, December 1, 1993; 270(21): 2590 - 2597.
[Abstract] [PDF]


Home page
ScienceHome page
M. Keating
Response
Science, June 25, 1993; 260(5116): 1962 - 1962.
[PDF]